Azacitidine or intensive chemotherapy for older patients with secondary or therapy-related acute myeloid leukemia

The treatment of older patients with acute myeloid leukemia that is secondary to previous myelodysplastic syndrome, myeloproliferative neoplasm, or prior cytotoxic exposure remains unsatisfactory. We compared 92 and 107 patients treated, respectively, with intensive chemotherapy or azacitidine withi...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncotarget
Главные авторы: Dumas, Pierre-Yves, Bertoli, Sarah, Bérard, Emilie, Médiavilla, Clémence, Yon, Edwige, Tavitian, Suzanne, Leguay, Thibaut, Huguet, Françoise, Forcade, Edouard, Milpied, Noël, Sarry, Audrey, Sauvezie, Mathieu, Bories, Pierre, Pigneux, Arnaud, Récher, Christian
Формат: Artigo
Язык:Inglês
Опубликовано: Impact Journals LLC 2017
Предметы:
Clinical Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5668025/
https://ncbi.nlm.nih.gov/pubmed/29108292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15988
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы